2022 Taiwanese Dermatological Association (TDA), Taiwanese Association for Psoriasis and Skin Immunology (TAPSI), and Taiwan Society of cardiology (TSOC) joint consensus recommendations for the management of psoriatic disease with attention to cardiovascular comorbidities

Ching Chi Chi, Yen Wen Wu, Ting Hsing Chao, Chih Chiang Chen, Yi Ju Chen, Hao Min Cheng, Hsien Yi Chiu, Yu Wei Chiu, Wen Hung Chung, Tsu Yi Hsieh, Po Hsun Huang, Yu Huei Huang, Shang Hung Lin, Tsung Hsien Lin, Kwo Chang Ueng, Chun Chieh Wang, Yu Chen Wang, Nan Lin Wu, Charles Jia-Yin Hou*, Tsen Fang Tsai*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Psoriatic disease is a chronic inflammatory disorder with skin and joint manifestations. Due to the persistent inflammatory state exhibited by patients with psoriasis, multiple systemic comorbidities occur more frequently in patients with psoriasis than in the general population, and the risk of cardiovascular (CV) diseases is significantly increased. As the pathophysiology of psoriatic disease is becoming better understood, the sharing of underlying pathogenic mechanisms between psoriatic and CV diseases is becoming increasingly apparent. Consequently, careful attention to CV comorbidities that already exist or may potentially develop is needed in the management of patients with psoriasis, particularly in the screening and primary prevention of CV disease and in treatment selection due to potential drug–drug and drug-disease interactions. Furthermore, as the use of effective biologic therapy and more aggressive oral systemic treatment for psoriatic disease is increasing, consideration of the potential positive and negative effects of oral and biologic treatment on CV disease is warranted. To improve outcomes and quality of care for patients with psoriasis, the Taiwanese Dermatological Association, the Taiwanese Association for Psoriasis and Skin Immunology, and the Taiwan Society of Cardiology established a Task Force of 20 clinicians from the fields of dermatology, cardiology, and rheumatology to jointly develop consensus expert recommendations for the management of patients with psoriatic disease with attention to CV comorbidities.

Original languageEnglish
Pages (from-to)442-457
Number of pages16
JournalJournal of the Formosan Medical Association
Volume122
Issue number6
DOIs
StatePublished - Jun 2023

Keywords

  • Cardiovascular
  • Comorbidities
  • Consensus
  • Psoriasis
  • Recommendations
  • Taiwan

Fingerprint

Dive into the research topics of '2022 Taiwanese Dermatological Association (TDA), Taiwanese Association for Psoriasis and Skin Immunology (TAPSI), and Taiwan Society of cardiology (TSOC) joint consensus recommendations for the management of psoriatic disease with attention to cardiovascular comorbidities'. Together they form a unique fingerprint.

Cite this